CDH2 and prostate cancer: Consistent with the results, accumulation of FGF19 in cytoplasm was shown in poorly differentiated prostate cancer cells in human prostate cancer tissues derived from radical prostatectomy, and the presence of FGF19-positive tissues correlated with positive immuno-histochemical staining with N-cadherin in prostate cancer tissues [60].